FIELD: organic chemistry, pharmacy. SUBSTANCE: invention relates to new compounds of the formula (I) where R1 means a group of the formula (1a) or (1b) where R7 means optionally substituted hydroxy-group, acyloxy-group, halogen atom, -OR10 where R10 means lower alkyl optionally substituted with -O(CH2)mOH where m is a number from 2 to 4 or -OCONH2; R7a means hydrogen atom; or R7 and R7a mean oxo-group; R8 means hydroxy- or methoxy-group and R9 means hydroxy- or acyloxy-group; R2 means hydrogen atom, acyloxy- -group or optionally substituted hydroxy-group; between two carbon atoms bound with dotted line - a simple or double bond exists; R3 means methyl, ethyl, n-propyl or allyl; or R4 means hydrogen atom or hydroxy-group and R4a means hydrogen atom; or R4 and R4a mean oxo-group; or R5 means hydroxy-group and R5a means hydrogen atom; or R5 and R5a/ mean oxo-group; A means a group of the formula -CH(OR6)-CH2-(CH2)n or -CH= CH-(CH2)n- bound with carbon atom through (CH2)n-; R6 means lower alkyl and n = 1 or 2. Compounds can be in free form or as salts. These compounds are used as pharmaceutical preparations, especially as anti-inflammatory and antiprofilerative agents. EFFECT: enhanced effectiveness of compounds as curative agents. 9 cl, 4 tbl, 36 ex
Authors
Dates
1999-05-20—Published
1994-05-26—Filed